NCT05286528 Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database Status COMPLETED Phase N/A
NCT05286281 A Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803 Status COMPLETED Phase PHASE1
NCT05269069 Impact of Rheumatoid Arthritis on Body Composition, Bone Marrow Adiposity and Bone Mineral Density: a Case-control Study Status TERMINATED Phase N/A
NCT05266105 A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05264493 Bioavailability Study of Naloxone 5 Milligrams (mg) Intramuscular (IM) Autoinjector Status COMPLETED Phase PHASE1
NCT05263921 Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants Status COMPLETED Phase PHASE1
NCT05263908 A Study to Learn About PAXLOVID (a Commercial Medicine) In People With COVID-19 Status COMPLETED Phase N/A
NCT05263895 Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation Status COMPLETED Phase PHASE1
NCT05263609 Optimizing Pembrolizumab Therapy With Timing and Intensification With Axitinib Status WITHDRAWN Phase PHASE2
NCT05262517 Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders Status TERMINATED Phase PHASE3
NCT05262400 A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05261490 Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT05261139 EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease Status RECRUITING Phase PHASE3
NCT05260684 Comparative Effectiveness of Targeted Therapies in BRAF Positive Metastatic Melanoma in the US Status COMPLETED Phase N/A
NCT05259397 PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) Status WITHDRAWN Phase PHASE1
NCT05257798 A Study to Learn About The Study Medicine (Called PF-06823859) in Healthy Chinese Participants Status COMPLETED Phase PHASE1
NCT05250115 A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis Status TERMINATED Phase N/A
NCT05249569 Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma Status TERMINATED Phase PHASE2
NCT05248997 Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis Status COMPLETED Phase PHASE3